Product/Composition:- | Atazanavir |
---|---|
Strength:- | 150 mg, 200 mg, 300 mg |
Form:- | Capsules |
Reference Brands:- | Reyataz®(EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Atazanavir Capsules (150–300 mg), sold under brands like Reyataz® and Atavir®, are protease inhibitors for HIV-1 treatment. Widely used in combination therapy, they’re available for bulk procurement on PharmaB2B platforms from WHO-GMP suppliers—ideal for tenders, NGOs, and HIV programs.
Atazanavir Capsules, marketed globally under brands like Reyataz®, Atavir®, and Atazor®, are essential protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 treatment. Available in 150 mg, 200 mg, and 300 mg strengths, Atazanavir is often co-administered with Ritonavir to boost its effectiveness. With WHO and USFDA endorsements, PharmaB2B platforms enable global sourcing from GMP-certified manufacturers for bulk procurement, tenders, and public health supply chains. This once-daily dosing option is well-tolerated and vital in global HIV management programs. Partner with trusted suppliers to ensure quality and cost-effective access to key antiretroviral medicines.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications